Abstract:1299 Since 1977, numerous studies have indicated the existence of a putative membrane-based estrogen receptor. However, the identity of this membrane-based estrogen receptor has not been established. Through an extensive homology search in Gene Bank, we recently identified and cloned a novel variant of ER-Α with a predicted molecular weight of 35.7 kDa. The transcript of this ER-Α variant is initiated from a previously unidentified promoter in the first intron of the original ER-Α gene. This ER-Α variant differs from the original ER-Α by lacking both transcriptional activation domains (AF-1 and AF-2) but retaining the dimerization, DNA-binding and partial ligand-binding domains. Its ligand-binding domain also possesses a unique 27 amino acid stretch that replaces the last 138 amino acids of the ER-Α. In transient transfection assays, this ER-Α variant exhibited no intrinsic transcriptional activity but strongly inhibited ligand-dependent and -independent transactivation activities mediated by the original ER-Α and ER-Β. Immunodetection and subcellular fractionation assays demonstrated that this ER-Α variant is expressed on the plasma membrane of mammary epithelial cells, and also in the cytoplasm and nucleus. In cells that express this ER-Α variant, 17Β-estradiol (E2) treatment activated a membrane-initiated effect of estrogen signaling by transiently activating the mitogen-activated protein kinase (MAPK) pathway that led to cell proliferation. Antiestrogens such as tamoxifen and ICI 182,780, however, strongly and persistently activated the MAPK pathway that then resulted in activation of the SAPK/JNK pathway. Immunohistochemistry analysis using a specific antibody aganst this ER-Α variant revealed that 26 of 38 cases (68%) breast cancer specimens examined express this ER-Αvariant on the plasma membrane and cytoplasm, and 12 out of 13 ER-negative breast caner specimens also express this ER-Α variant. Our findings demonstrate a physiologically important ER-Α variant that is involved in membrane-initiated estrogen signaling and suggest that aberrant expression of this ER-Α variant contributes to development of ER-positive and-negative human breast cancer.

[Expression and Significance of Estrogen Receptor Isoforms in the Development of Human Breast Carcinoma].

Estrogen Receptor Beta Variants Mrna Expressions in Gastric Cancer Tissues and Association with Clinicopathologic Parameters

Prognostic Role of Estrogen Receptor Α and Estrogen Receptor Β in Gastric Cancer

Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer.

Expression of Androgen Receptor in Breast Cancer and Its Prognostic Significance

Expression of ERα36 in gastric cancer samples and their matched normal tissues.

Expressions of estrogen receptor-related receptor alpha and estrogen receptors in endometrial carcinoma

Expression of Estrogen Receptor-Related Receptor Isoforms in Endometrial Carcinoma Tissues and Its Clinical Significance

Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues.

[Expression of Estrogen Receptor-Related Receptor Alpha and Estrogen Receptor Alpha in Endometrial Carcinoma and the Primary Investigation of Their Clinical Significance].

Expression and Significance of Estrogen Receptor Α and Β in Prostate Cancer and Peri-Cancer Tissue

A novel variant of estrogen receptor-alpha is expressed in ER-negative breast cancer and mediates membrane-initiated estrogen signaling

Expression of Estrogen and Progesterone Receptor Subtypes in Human Endometrial Carcinoma Tissues

Distribution and Prognostic Significance of Estrogen Receptors Expression in Prostate Cancer

[Expression of estrogen receptor, progesterone receptor, and human epithelial growth factor receptor 2 in breast cancer and the significance thereof: analysis of 910 cases].

The Expression of ERβ Protein Correlates with Vascular Endothelial Growth Factor and Its Prognostic Significance in Human Breast Cancer

Expression of ER-α36, a novel variant of estrogen receptor in endometrial carcinoma and its clinical significance.

Estrogen Receptor Alpha Variant Er Alpha 46 Mediates Growth Inhibition and Apoptosis of Human Ht-29 Colon Adenocarcinoma Cells in the Presence of 17 Beta-Oestradiol

Expression of Estrogen Receptor-Related Receptor Isoforms and Clinical Significance in Endometrial Adenocarcinoma

[In Vitro Study of the Effects of Estrogen Receptor Beta Expression on the Biological Behavior of a Human Breast Cancer Cell Line].

A primary study on the expression of estrogen receptor α36 in endometrial carcinoma tissues